<PubmedArticle>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">27307782</PMID>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1608-9685</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>22</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>2016</MedlineDate>
</PubDate>
</JournalIssue>
<Title>The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa</Title>
<ISOAbbreviation>S Afr J Psychiatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">a852</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Substance use and psychiatric disorders cause significant burden of disease in low- and middle-income countries. Co-morbid psychopathology and longer duration of untreated psychosis (DUP) can negatively affect treatment outcomes.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The study assessed substance use amongst adults with severe mental illness receiving services at a regional psychiatric hospital in KwaZulu-Natal (South Africa). We describe the prevalence and correlates of lifetime substance use and examine the association between substance use and DUP.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional survey recruited adults diagnosed with severe mental illness and assessed lifetime and past 3-month substance use using the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test. Regression analyses were conducted to determine associations between lifetime substance use (other than alcohol and tobacco) and DUP as measured by the World Health Organization Encounter Form.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Amongst 87 participants, alcohol (81.6%), tobacco (75.6%) and cannabis (49.4%) were the most common substances reported for lifetime use. Risk of health-related problems (health, social, financial, legal and relationship) of cannabis use was associated with younger age, single marital status and lower education. Adjusted regression analyses indicated that use of amphetamines and methaqualone is associated with longer DUP.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Substance use is prevalent amongst psychiatric patients in KwaZulu-Natal and may contribute to longer DUP. Mental health services in this region should address co-morbid substance use and psychiatric disorders.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Davis</LastName>
<ForeName>Glen P</ForeName>
<Initials>GP</Initials>
<AffiliationInfo>
<Affiliation>Columbia University Medical Center, Department of Psychiatry, New York, NY, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tomita</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>University of KwaZulu-Natal, Nelson R. Mandela School of Medicine, Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baumgartner</LastName>
<ForeName>Joy Noel</ForeName>
<Initials>JN</Initials>
<AffiliationInfo>
<Affiliation>Duke Global Health Institute, Duke University, Durham, NC, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mtshemla</LastName>
<ForeName>Sisanda</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>University of KwaZulu-Natal, Nelson R. Mandela School of Medicine, Durban, South Africa; KwaZulu-Natal Department of Health, Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nene</LastName>
<ForeName>Siphumelele</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Health Economics and HIV/AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>King</LastName>
<ForeName>Howard</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>University of KwaZulu-Natal, Nelson R. Mandela School of Medicine, Durban, South Africa; KwaZulu-Natal Department of Health, Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Susser</LastName>
<ForeName>Ezra</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Columbia University Mailman School of Public Health, Department of Epidemiology, New York, NY, United States of America; New York State Psychiatric Institute, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burns</LastName>
<ForeName>Jonathan K</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>University of KwaZulu-Natal, Nelson R. Mandela School of Medicine, Durban, South Africa; KwaZulu-Natal Department of Health, Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R25 TW009337</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 MH093296</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R24 TW007988</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 DA007294</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 MH013043</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>05</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>South Africa</Country>
<MedlineTA>S Afr J Psychiatr</MedlineTA>
<NlmUniqueID>100958626</NlmUniqueID>
<ISSNLinking>1608-9685</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27307782</ArticleId>
<ArticleId IdType="doi">10.4102/sajpsychiatry.v22i1.852</ArticleId>
<ArticleId IdType="pmc">PMC4904841</ArticleId>
<ArticleId IdType="mid">NIHMS790631</ArticleId>
</ArticleIdList>
<?nihms ?>
<ReferenceList>
<Reference>
<Citation>Am J Psychiatry. 2005 Oct;162(10):1785-804</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16199825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Addiction. 2002 Aug;97(8):969-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12144599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Afr J Psychiatry (Johannesbg). 2010 Nov;13(5):395-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21390411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Psychopharmacol. 2012 May;27(3):338-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22585594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Psychiatry. 2012 Dec 05;12:221</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23216941</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2013 Jan;13(1):10-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23257221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Med. 2000 Sep;30(5):1155-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12027051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Subst Use Misuse. 2010 Nov;45(13):2221-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21039113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Addict. 2015 Dec;24(8):768</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26767451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Schizophr Res. 2013 Aug;148(1-3):93-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23746486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Int AIDS Soc. 2009 Sep 16;12:18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19758444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Schizophr Res. 2012 Nov;141(2-3):215-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23006501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Psychiatry. 2008 Sep;193(3):203-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18757977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Addiction. 2002 Sep;97(9):1183-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12199834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Behav. 2014 Jul;18(7):1378-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24370963</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2013 Nov 9;382(9904):1575-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23993280</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Assessment. 2013 Dec;20(6):670-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22619394</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Afr J Psychiatry (Johannesbg). 2009 Aug;12(3):213-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19750250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>S Afr Med J. 2009 May;99(5 Pt 2):358-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19588799</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2012;18(32):5093-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22716138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pan Afr Med J. 2014 Jan 18;17 Suppl 1:8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24643118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>S Afr Med J. 2010 Oct 01;100(10):662-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21080996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Behav. 2014 Mar;18(3):511-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23955659</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatr Serv. 2002 Apr;53(4):437-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11919357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Addict. 2014 Nov-Dec;23(6):519-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24102874</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>